Phargomed El Salvador
WhatsApp
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-chlorophenyl)-6-hydroxy-tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine, 95%, (99% ee)

Strem Chemicals

(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-chlorophenyl)-6-hydroxy-tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine, 95%, (99% ee)

N° de parte: 15-8630

Ligands | Catalysts | Other Reagents

Cotizar por WhatsApp
El producto (3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-chlorophenyl)-6-hydroxy-tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine, 95%, (99% ee) de la marca Strem Chemicals, es un reactivo especializado que se utiliza en la investigación química y en aplicaciones de síntesis orgánica. Este compuesto, que pertenece a la categoría de ligandos y catalizadores, es ideal para laboratorios, universidades y clínicas en El Salvador que requieren alta pureza y eficacia en sus experimentos y procesos de desarrollo. Su formulación permite optimizar reacciones específicas, beneficiando a investigadores y profesionales en el ámbito científico que buscan resultados precisos y confiables. Phargomed El Salvador es el distribuidor autorizado de Strem Chemicals, ofreciendo entrega en todo el país y soporte local para garantizar la satisfacción de sus clientes. Para obtener más información y solicitar una cotización en dólares, no dude en contactarnos por WhatsApp.

Productos relacionados

(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-tricyclohexylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-tricyclohexylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%

(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 95%, (99% ee)

(11aR)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 95%, (99% ee)